Funding gaps prevent new diagnostics from moving consistently into care, report warns

Gaps in NHS funding and commissioning are preventing new diagnostics from moving consistently into routine care, a new report warns.

(c) Nonacus

(c) Nonacus

The Faster Answers report, published by Birmingham-based cancer diagnostics company Nonacus, warns access to evidence-backed diagnostics can still depend on local funding and commissioning decisions, even where there is growing evidence of clinical and NHS benefit. 

Nonacus says a non-invasive, urine-based test such as its GALEAS Bladder offers a way to ease pressure on cystoscopy capacity while catching cases earlier, before they escalate to emergency presentation.

Jayne Douglas-Moore, consultant urological surgeon at Leicester NHS Trust, one of eight NHS sites using the technology, said: ‘Bringing GALEAS Bladder into the NHS in Leicester represents a genuine turning point in bladder cancer diagnostics. A reliable non-invasive test to risk-stratify patients with haematuria has been long awaited, and the early results are promising.'

The Leicester pathway is supported by time-limited funding due to end in April 2027, leaving clinicians concerned about how the service can continue without a sustainable commissioning route.

Five-year survival is around 75% when bladder cancer is diagnosed at stage 1, falling to around 10% at stage 4. Around 1,700 people a year in England are diagnosed at stage 3 or 4.

Nonacus is calling on:

  • NICE to consider the latest real-world evidence on urinary biomarkers as part of future bladder cancer guidance and to clarify how evidence-backed risk-stratification tools can be incorporated into the pathway
  • NHS England and Getting It Right First Time to support more consistent evaluation and adoption of risk-stratification approaches across haematuria pathways, reducing variation between local systems
  • DHSC to ensure funding, reimbursement and MedTech adoption routes allow evidence-backed diagnostics to move into routine NHS care where they demonstrate clinical and operational value.

'Maze of bureaucracy' preventing GPs from fulfilling neighbourhood health vision

'Maze of bureaucracy' preventing GPs from fulfilling neighbourhood health vision

By Lee Peart 20 November 2026

GPs seeking to repurpose their practices as neighbourhood health centres face a ‘maze of bureaucracy’, MPs have found.

BREAKING NEWS: Milburn sets 10-year ambition to end long-term youth employment

By Lee Peart 17 November 2026

Former health secretary Alan Milburn today set out a 10-year target to ending long-term youth employment in his review of the UK’s NEET crisis.

First ever targeted treatment for anal cancer rolled out

By Lee Peart 12 November 2026

The first ever targeted treatment for anal cancer for NHS patients living with advanced anal cancer is being rolled out.


Popular articles by Lee Peart